Discovery of the Potent and Selective Inhaled Janus Kinase 1 Inhibitor AZD4604 and Its Preclinical Characterization

被引：6

作者：

Nilsson, Magnus ^{[1
]}

Berggren, Kristina ^{[1
]}

Berglund, Susanne ^{[1
]}

Cerboni, Silvia ^{[2
]}

Collins, Mia ^{[2
]}

Dahl, Goran ^{[3
]}

Elmqvist, David ^{[4
]}

Grimster, Neil P. ^{[5
]}

Hendrickx, Ramon ^{[6
]}

Johansson, Johan R. ^{[1
]}

Kettle, Jason G. ^{[5
]}

Lepisto, Matti ^{[1
]}

Rhedin, Magdalena ^{[2
]}

Smailagic, Amir ^{[2
]}

Su, Qibin ^{[5
]}

Wennberg, Tiiu ^{[2
]}

Wu, Allan ^{[7
]}

Osterlund, Torben ^{[8
]}

Naessens, Thomas ^{[2
]}

Mitra, Suman ^{[2
]}

机构：

[1] AstraZeneca, BioPharmaceut R&D, Resp & Immunol, Med Chem Res & Early Dev, SE-43183 Gothenburg, Sweden

[2] AstraZeneca, BioPharmaceut R&D, Resp & Immunol, Biosci Res & Early Dev, SE-43183 Gothenburg, Sweden

[3] AstraZeneca, BioPharmaceut R&D, Struct & Biophys Res & Early Dev, Discovery Sci, SE-43183 Gothenburg, Sweden

[4] AstraZeneca, BioPharmaceut R&D, Pharmaceut Sci, Early Prod Dev, SE-43183 Gothenburg, Sweden

[5] AstraZeneca R&D, Oncol R&D, Waltham, MA 02451 USA

[6] AstraZeneca, BioPharmaceut R&D, Res & Early Dev, Resp & Immunol,DMPK, SE-43183 Gothenburg, Sweden

[7] AstraZeneca R&D, Discovery Sci, R&D, Waltham, MA 02451 USA

[8] AstraZeneca, BioPharmaceut R&D, Res & Early Dev, Discovery Sci,Mechanist Biol & Profiling, SE-43183 Gothenburg, Sweden

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2023年

关键词：

T-CELLS; TISSUE DISTRIBUTION; JAK1; INHIBITORS; IMMUNITY; IDENTIFICATION; MECHANISMS;

D O I：

10.1021/acs.jmedchem.3c00554

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

JAK-STAT cytokines are critical in regulating immunity. Persistent activation of JAK-STAT signaling pathways by cytokines drives chronic inflammatory diseases such as asthma. Herein, we report on the discovery of a highly JAK1-selective, ATP-competitive series of inhibitors having a 1000-fold selectivity over other JAK family members and the approach used to identify compounds suitable for inhaled administration. Ultimately, compound 16 was selected as the clinical candidate, and upon dry powder inhalation, we could demonstrate a high local concentration in the lung as well as low plasma concentrations, suggesting no systemic JAK1 target engagement. Compound 16 has progressed into clinical trials. Using 16, we found JAK1 inhibition to be more efficacious than JAK3 inhibition in IL-4-driven Th2 asthma.

引用

页码：13400 / 13415

页数：16

共 50 条

[31] Discovery of higenamine as a potent, selective and cellular active natural LSD1 inhibitor for MLL-rearranged leukemia therapy [J].

Fang, Yuan ;

Yang, Chao ;

Teng, Dehong ;

Su, Shiwei ;

Luo, Xiang ;

Liu, Zhongqiu ;

Liao, Guochao .

BIOORGANIC CHEMISTRY, 2021, 109

[32] Discovery of PF-07265028, A Selective Small Molecule Inhibitor of Hematopoietic Progenitor Kinase 1 (HPK1) for the Treatment of Cancer [J].

Gallego, Rebecca A. ;

Cho-Schultz, Sujin ;

Del Bel, Matthew ;

Dechert-Schmitt, Anne-Marie ;

Donaldson, Joyann S. ;

He, Mingying ;

Jalaie, Mehran ;

Kania, Rob ;

Matthews, Jean ;

Mctigue, Michele ;

Tuttle, Jamison B. ;

Risley, Hud ;

Zhou, Dahui ;

Zhou, Ru ;

Ahmad, Omar K. ;

Bernier, Louise ;

Berritt, Simon ;

Braganza, John ;

Chen, Zecheng ;

Cianfrogna, Julie A. ;

Collins, Michael ;

Jones, Cinthia Costa ;

Cronin, Ciaran N. ;

Davis, Carl ;

Dress, Klaus ;

Edwards, Martin ;

Farrell, William ;

France, Scott P. ;

Grable, Nicole ;

Johnson, Eric ;

Johnson, Ted W. ;

Jones, Rhys ;

Knauber, Thomas ;

Lafontaine, Jennifer ;

Loach, Richard P. ;

Maestre, Michael ;

Miller, Nichol ;

Moen, Mark ;

Monfette, Sebastien ;

Morse, Peter ;

Nager, Andrew Ross ;

Niosi, Mark ;

Richardson, Paul ;

Rohner, Allison K. ;

Sach, Neal W. ;

Timofeevski, Sergei ;

Tucker, Joseph W. ;

Vetelino, Beth ;

Zhang, Lei ;

Nair, Sajiv K. .

JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (24) :22002-22038

[33] Preclinical characterization of itacitinib (INCB039110), a novel selective inhibitor of JAK1, for the treatment of inflammatory diseases [J].

Covington, Maryanne ;

He, Xin ;

Scuron, Monika ;

Li, Jun ;

Collins, Robert ;

Juvekar, Ashish ;

Shin, Niu ;

Favata, Margaret ;

Gallagher, Karen ;

Sarah, Sarala ;

Xue, Chu-biao ;

Peel, Michael ;

Burke, Krista ;

Oliver, Julian ;

Fay, Brittany ;

Yao, Wenqing ;

Huang, Taisheng ;

Scherle, Peggy ;

Diamond, Sharon ;

Newton, Robert ;

Zhang, Yan ;

Smith, Paul .

EUROPEAN JOURNAL OF PHARMACOLOGY, 2020, 885

[34] Development and validation of an HPLC-MS/MS method for the determination of filgotinib, a selective Janus kinase 1 inhibitor: Application to a metabolic stability study [J].

AlRabiah, Haitham ;

Kadi, Adnan A. ;

Attwa, Mohamed W. ;

Mostafa, Gamal A. E. .

JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2020, 1154

[35] Discovery of a benzo[e]pyrimido-[5,4-b][1,4]diazepin-6(11H)-one as a Potent and Selective Inhibitor of Big MAP Kinase 1 [J].

Deng, Xianming ;

Yang, Qingkai ;

Kwiatkowski, Nicholas ;

Sim, Taebo ;

McDermott, Ultan ;

Settleman, Jeffrey E. ;

Lee, Jiing-Dwan ;

Gray, Nathanael S. .

ACS MEDICINAL CHEMISTRY LETTERS, 2011, 2 (03) :195-200

[36] Characterization of Pharmacologic and Pharmacokinetic Properties of CCX168, a Potent and Selective Orally Administered Complement 5a Receptor Inhibitor, Based on Preclinical Evaluation and Randomized Phase 1 Clinical Study [J].

Bekker, Pirow ;

Dairaghi, Daniel ;

Seitz, Lisa ;

Leleti, Manmohan ;

Wang, Yu ;

Ertl, Linda ;

Baumgart, Trageen ;

Shugarts, Sarah ;

Lohr, Lisa ;

Dang, Ton ;

Miao, Shichang ;

Zeng, Yibin ;

Fan, Pingchen ;

Zhang, Penglie ;

Johnson, Daniel ;

Powers, Jay ;

Jaen, Juan ;

Charo, Israel ;

Schall, Thomas J. .

PLOS ONE, 2016, 11 (10)

[37] Discovery of Imidazo[1,2-b]pyridazine Derivatives as Potent and Highly Selective Irreversible Bruton's Tyrosine Kinase (BTK) Inhibitors [J].

Zhang, Dandan ;

Zhao, Jie ;

Xu, Guiqing ;

Wang, Yue ;

Li, Yang ;

Ren, Hanxiao ;

Geng, Jiajun ;

Du, Yu ;

Zhang, Chenchen ;

Yang, Shouning ;

Liu, Dongfang ;

Gao, Jiajing ;

Xiong, Yi ;

Zhang, Haoyi ;

Li, Wei ;

Wang, Wei ;

Wang, Di ;

Li, Biao ;

He, Xing ;

Ma, Chunhua ;

Jiang, Yuqin ;

Ding, Qingjie .

JOURNAL OF MEDICINAL CHEMISTRY, 2025, 68 (11) :10897-10929

[38] Discovery of a potent and highly selective inhibitor of ataxia telangiectasia mutated and Rad3-Related (ATR) kinase: Structural activity relationship and antitumor activity both in vitro and in vivo [J].

Bin, Huachao ;

Chen, Pei ;

Wu, Ming ;

Wang, Falu ;

Lin, Guifeng ;

Pan, Shulei ;

Liu, Jingming ;

Mu, Bo ;

Nan, Jinshan ;

Huang, Qiao ;

Li, Linli ;

Yang, Shengyong .

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 232

[39] Discovery of a Potent, Selective, and Orally Available Class I Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Kinase Inhibitor (GDC-0980) for the Treatment of Cancer [J].

Sutherlin, Daniel P. ;

Bao, Linda ;

Berry, Megan ;

Castanedo, Georgette ;

Chuckowree, Irina ;

Dotson, Jenna ;

Folks, Adrian ;

Friedman, Lori ;

Goldsmith, Richard ;

Gunzner, Janet ;

Heffron, Timothy ;

Lesnick, John ;

Lewis, Cristina ;

Mathieu, Simon ;

Murray, Jeremy ;

Nonomiya, Jim ;

Pang, Jodie ;

Pegg, Niel ;

Prior, Wei Wei ;

Rouge, Lionel ;

Salphati, Laurent ;

Sampath, Deepak ;

Tian, Qingping ;

Tsui, Vickie ;

Wan, Nan Chi ;

Wang, Shumei ;

Wei, BinQing ;

Wiesmann, Christian ;

Wu, Ping ;

Zhu, Bing-Yan ;

Olivero, Alan .

JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (21) :7579-7587

[40] The PARP1 selective inhibitor saruparib (AZD5305) elicits potent and durable antitumor activity in patient-derived BRCA1/2-associated cancer models [J].

Herencia-Ropero, Andrea ;

Llop-Guevara, Alba ;

Staniszewska, Anna D. ;

Domenech-Vivo, Joanna ;

Garcia-Galea, Eduardo ;

Moles-Fernandez, Alejandro ;

Pedretti, Flaminia ;

Domenech, Heura ;

Rodriguez, Olga ;

Guzman, Marta ;

Arenas, Enrique J. ;

Verdaguer, Helena ;

Calero-Nieto, Fernando J. ;

Talbot, Sara ;

Tobalina, Luis ;

Leo, Elisabetta ;

Lau, Alan ;

Nuciforo, Paolo ;

Dienstmann, Rodrigo ;

Macarulla, Teresa ;

Arribas, Joaquin ;

Diez, Orland ;

Gutierrez-Enriquez, Sara ;

Forment, Josep V. ;

O'Connor, Mark J. ;

Albertella, Mark ;

Balmana, Judith ;

Serra, Violeta .

GENOME MEDICINE, 2024, 16 (01)

← 1 2 3 4 5 →